...
首页> 外文期刊>Stem cell research >Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation - ScienceDirect
【24h】

Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation - ScienceDirect

机译:从具有致病性IDS突变的3岁男性中产生II型粘多糖贮积病(MPS II)人类诱导的多能干细胞(iPSC)系-ScienceDirect

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Peripheral blood was collected from a 3-year-old male patient with an X-linked recessive mutation of Iduronate 2-sulfatase (IDS) gene (NM_000202.7(IDS):c.85C??T) causing MPS II (OMIM 309900). Peripheral blood mononuclear cells (PBMCs) were reprogrammed by lentiviral delivery of a self-silencing hOKSM polycistronic vector. The pluripotency of the iPSC line was confirmed by the expression of pluripotency-associated markers and in vitro spontaneous differentiation towards the 3 germ layers. The iPSC line showed normal karyotype. The cell line offers a good platform to study MPS II pathophysiology, for drug testing, early biomarker discovery and gene therapy studies.
机译:收集一名3岁男性患者的外周血,该患者患有X连锁的Iduronate 2-硫酸酯酶(IDS)基因的隐性突变(NM_000202.7(IDS):c.85C?>?T),引起MPS II(OMIM) 309900)。通过自我沉默的hOKSM多顺反子载体的慢病毒递送,重新编程外周血单核细胞(PBMC)。 iPSC品系的多能性通过多能性相关标记的表达和体外自发向3个胚层的分化来证实。 iPSC品系显示正常核型。该细胞系为研究MPS II病理生理学,药物测试,早期生物标志物发现和基因疗法研究提供了一个很好的平台。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号